Abstract 2360: Single-center lupus pregnancy cohort found that: 🔹 Absence of DORIS remission associated w/ adverse pr https://pbs.twimg.com/profile_images/1590198200824000512/8_JyVKFt_normal.jpg john+RNV2@john… Tue, […]
Reaadmissions in sle pregnancies from 66k patients Insurance and economics seem to be very important in predictions usin https://pbs.twimg.com/profile_images/1248272740831735809/C0SA-iJf_normal.jpg john+RNV2@john…
Disparities in Physical Function in SLE tammytilley@gm… Tue, 10/28/2025 – 16:45 Lupus Drs. Mrinalini Dey and Laura Plantinga discuss abstracts
Novel Insights into Sjogren’s Disease tammytilley@gm… Tue, 10/28/2025 – 16:39 General Rheumatology Sjogrens Dr. Janet Pope reporting on abstract 1684
The Power of Gamma Delta T Cell for Autoimmunity tammytilley@gm… Tue, 10/28/2025 – 14:55 Education/ACR/EULAR Lupus Drs. Yuz Yusof and
Are the clues of RA there in the EMR, before the diagnosis is made? Jina off-the-shelf AI with subsequent retraining
Adverse events from avacopan the WHO pharmacovigilence database (VigiBase) Not a lot new – infections happen, hepatic e https://pbs.twimg.com/profile_images/1982460526815764480/EQEuBdmh_normal.jpg john+RNV2@john…
In a 4-year study of 85 SpA patients, ChatGPT-4o matched SPSS in analyzing NLR/PLR trends. Outputs were identical, but C
Eder et al. Deucravacitinib in PsA from POETYK-PsA stuides. Male and female patients had similar response rates at week https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg
Infection vs steroid sparing in PMR/GCA/AAV studies with steroid-sparing Rx GiACTA (1, top right) aside, – low infectio https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4_normal.jpg john+RNV2@john…
In the CLOSE-UP study of UPA in RA – 61% in remission with responses sustained to 24 mo – Benefit
Serrano-Combarro et al. Abatacept in RA-ILD. 343 patients. Progressive ILD in 23%. Similar to the numbers progressing on https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg john+RNV2@john…
#ACR25 Abstr#LB10 Promising 4-Year data of Deucravacitinib in blinded phase 2 RCT +LTE study showed efficacy inc. LLDAS https://pbs.twimg.com/profile_images/1625445768768135171/M24lCgC__normal.jpg john+RNV2@john…
#ACR25 How hard will you go & at what cost? A study in China using CD20/BCMA Bispecific autologous CAR-T showed
Putting Steroid Tapering into Practice in SLE tammytilley@gm… Tue, 10/28/2025 – 14:15 Lupus Drug Safety Steroids Drs. Yuz Yusof and
Another Specialized Biomarker in PsA tammytilley@gm… Tue, 10/28/2025 – 14:14 Psoriatic arthritis Labs/Biomarkers Dr. Elaine Husni discusses abstract 0529 (Anti-PeptidylArginine
Addressing Lupus Nephritis Early tammytilley@gm… Tue, 10/28/2025 – 13:06 Lupus Labs/Biomarkers Outcomes Dr. Andrea Fava at the 2025 ACR Convergence
Semaglutide isn’t just for weight loss? In RA, users had 20–40% lower risk of synovitis, stiffness & swelling u https://pbs.twimg.com/profile_images/1525262133575012354/Lfut18gD_normal.jpg
Mateo Faxas et al. TriNetX study, propensity score matched. 3000 patients. Arrythmia risk is higher with IL-6i vs TNFi i
PLEX continues to be OUT for DAH in AAV Retrospective review of ~1.4k AAV-DAH pt 375 who received PLEX compared
Adding social risk factors to the mix Abstract 1917: WashU Rheumatology examined SRF screening in the clinic 🔹 50% s
Heydari-Kamjani et al. TriNetX study. 28973 PsA patients. IL-17i and IL-23i lower rates stroke, MI, DVT/PE than TNFi. IL https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg
Is taking NSAIDs +TNFi better for the joints? Abstract 2359: In radiographic axSpA, NSAIDS + TNFi associated with -fewe https://pbs.twimg.com/profile_images/1590198200824000512/8_JyVKFt_normal.jpg
Effect of air pollution in RA Prospective cohort 1000+pts w/ 12000+ visits Higher levels of pollution & specific s https://pbs.twimg.com/profile_images/1800478984926334976/yyyPLP4A_normal.jpg
The CAR T engine doesn’t stop! LB04: Phase 1 bispecific CD19/BCMA CAR T in refractory autoimmune disease 🚗💥 ✅ https://pbs.twimg.com/profile_images/1590198200824000512/8_JyVKFt_normal.jpg
Molina et al. 52 weeks of MANHATTAN study. Guselkumab vs second TNFi after failure 1st TNFi in PsA. MDA 52%
The Upper Hand in PsA? Not the Dominant One tammytilley@gm… Tue, 10/28/2025 – 11:38 Psoriatic arthritis General Rheumatology Dr. Aurelie
